Literature DB >> 26542657

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.

Barry J Maron, James E Udelson, Robert O Bonow, Rick A Nishimura, Michael J Ackerman, N A Mark Estes, Leslie T Cooper, Mark S Link, Martin S Maron.   

Abstract

Entities:  

Keywords:  ACC/AHA Scientific Statements; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy; cardiovascular abnormalities; cardiovascular magnetic resonance; hypertrophic cardiomyopathy; myocarditis; sudden death

Mesh：

Year:  2015        PMID： 26542657     DOI： 10.1016/j.jacc.2015.09.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  41 in total

Review 1.  Second Hits in Dilated Cardiomyopathy.

Authors:  Peter Marstrand; Kermshlise Picard; Neal K Lakdawala
Journal:  Curr Cardiol Rep       Date:  2020-01-24       Impact factor: 2.931

2.  Big heart, no longer a big problem: using catecholamine-based quantifications may be an effective means to prescribe exercise to non-obstructive hypertrophic cardiomyopathy patients.

Authors:  Steven Spector; Ryan Debi; Jin Shin
Journal:  J Physiol       Date:  2019-04-03       Impact factor: 5.182

Review 3.  Shared decision-making in HCM.

Authors:  Barry J Maron; Rick A Nishimura; Martin S Maron
Journal:  Nat Rev Cardiol       Date:  2017-01-27       Impact factor: 32.419

4.  Exercise Dose Associated With Military Service: Implications for the Clinical Management of Inherited Risk for Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Elena M Segre; Lydia D Hellwig; Clesson Turner; Craig P Dobson; Mark C Haigney
Journal:  Mil Med       Date:  2020-09-18       Impact factor: 1.437

5.  Non-compaction cardiomyopathy in an asymptomatic athlete.

Authors:  Margaret Kapor Manus; Satyajeet Roy; Rosemarie Stag; Daniel Hyman
Journal:  BMJ Case Rep       Date:  2016-08-17

6.  Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes.

Authors:  Brian Hainline; Jonathan Drezner; Aaron Baggish; Kimberly G Harmon; Michael S Emery; Robert J Myerburg; Eduardo Sanchez; Silvana Molossi; John T Parsons; Paul D Thompson
Journal:  J Athl Train       Date:  2016-04-25       Impact factor: 2.860

Review 7.  Medico-legal perspectives on sudden cardiac death in young athletes.

Authors:  Antonio Oliva; Vincenzo M Grassi; Oscar Campuzano; Maria Brion; Vincenzo Arena; Sara Partemi; Monica Coll; Vincenzo L Pascali; Josep Brugada; Angel Carracedo; Ramon Brugada
Journal:  Int J Legal Med       Date:  2016-09-21       Impact factor: 2.686

Review 8.  Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients.

Authors:  Thomas D Ryan; Rajaram Nagarajan; Justin Godown
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 9.  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Authors:  George Makavos; Chris Κairis; Maria-Eirini Tselegkidi; Theodoros Karamitsos; Angelos G Rigopoulos; Michel Noutsias; Ignatios Ikonomidis
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

10.  Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  Ankit B Shah; Mary Z Bechis; Marcel Brown; Jennifer Michaud Finch; Garrett Loomer; Erich Groezinger; Rory B Weiner; Meagan M Wasfy; Michael H Picard; Michael A Fifer; Gregory B Lewis; Aaron L Baggish
Journal:  J Physiol       Date:  2019-01-09       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.